Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Penn Pharma Completes First Phase of Expansion | Contract Pharma

What are you searching for?

Sign in
Breaking News

Penn Pharma Completes First Phase of Expansion

Penn Pharma has completed the first phase of its $19.7 million expansion program with a $.5 million investment extending its facilities by 2,400m2 and changing the transport and delivery infrastructure at its Tredegar headquarters.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Penn Pharma has completed the first phase of its $19.7 million expansion program with a $.5 million investment extending its facilities by 2,400m2 and changing the transport and delivery infrastructure at its Tredegar headquarters.

Darren Hassey, chief operating officer at Penn Pharma, said, “The recent developments to the site only add to our established offerings. By altering the externals of the site and moving the delivery and collection points we have in turn altered the internal factory processes, ensuring the smooth flow of people, process and materials.”

Peter George, chief executive officer of Penn Pharma, said, “By heavily investing in our Tredegar site it strengthens our commitment to the local community and as a leading Welsh company we will endeavor to pay back the Assembly Government’s faith in us by driving sustainable growth and employment.”

Additional phases of the expansion will take place during the next five years.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters